Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury.
about
Effects of diabetes and hypertension on macrophage infiltration and matrix expansion in the rat kidneyNatural Phyto-Bioactive Compounds for the Treatment of Type 2 Diabetes: Inflammation as a TargetEmerging role of mast cells and macrophages in cardiovascular and metabolic diseasesRole of T cells in type 2 diabetic nephropathyInflammation and oxidative stress in diabetic nephropathy: new insights on its inhibition as new therapeutic targetsLipid mediators are critical in resolving inflammation: a review of the emerging roles of eicosanoids in diabetes mellitusBiomarkers in chronic kidney disease, from kidney function to kidney damagePioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic ratsMacrophage TGF-β1 and the Proapoptotic Extracellular Matrix Protein BIGH3 Induce Renal Cell Apoptosis in Prediabetic and Diabetic ConditionsMonocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injuryAdenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy.Ruscogenin ameliorates diabetic nephropathy by its anti-inflammatory and anti-fibrotic effects in streptozotocin-induced diabetic rat.Renoprotective effect of rosiglitazone through the suppression of renal intercellular adhesion molecule-1 expression in streptozotocin-induced diabetic rats.Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic miceGene expression programs of mouse endothelial cells in kidney development and disease.Tanshinone IIA attenuates renal damage in STZ-induced diabetic rats via inhibiting oxidative stress and inflammation.Macrophage colony-stimulating factor and its receptor signaling augment glycated albumin-induced retinal microglial inflammation in vitro.CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice.Predicting diabetic nephropathy using a multifactorial genetic model.The MCP-1/CCR2 axis in podocytes is involved in apoptosis induced by diabetic conditions.Diabetic nephropathy is accelerated by farnesoid X receptor deficiency and inhibited by farnesoid X receptor activation in a type 1 diabetes modelCollagen XIII induced in vascular endothelium mediates alpha1beta1 integrin-dependent transmigration of monocytes in renal fibrosisThe role of Krüppel-like factor 4 in transforming growth factor-β-induced inflammatory and fibrotic responses in human proximal tubule cells.The protective role of Smad7 in diabetic kidney disease: mechanism and therapeutic potentialFrom fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy.Elongated membrane tethers, individually anchored by high affinity α4β1/VCAM-1 complexes, are the quantal units of monocyte arrests.Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathySesquiterpene lactones inhibit advanced oxidation protein product-induced MCP-1 expression in podocytes via an IKK/NF-κB-dependent mechanism.Therapeutic targets for treating fibrotic kidney diseasesInhibition of macrophage nuclear factor-kappaB leads to a dominant anti-inflammatory phenotype that attenuates glomerular inflammation in vivo.Inflammatory cytokines in diabetic nephropathy.Knockout of toll-like receptor-2 attenuates both the proinflammatory state of diabetes and incipient diabetic nephropathyAge-related renal disease in female Dahl salt-sensitive rats is attenuated with 17 beta-estradiol supplementation by modulating nitric oxide synthase expression.Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathySerum Levels of Progranulin Are Closely Associated with Microvascular Complication in Type 2 Diabetes.Therapeutic potential of digitoflavone on diabetic nephropathy: nuclear factor erythroid 2-related factor 2-dependent anti-oxidant and anti-inflammatory effect.Induction of hemeoxygenase-1 reduces glomerular injury and apoptosis in diabetic spontaneously hypertensive rats.Involvement of the NLRC4-Inflammasome in Diabetic Nephropathy.Elevated urinary excretion of immunoglobulins in nonproteinuric patients with type 1 diabetes.Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes
P2860
Q24810948-89599FD1-58C6-48EC-9AB8-B9D16A294348Q26741391-B4DA5EF5-A7A7-4188-9310-8977DB226106Q26825467-AF3CFB6E-CBE1-485A-A99B-102DA3A64670Q26849691-E4CB8EEE-6B27-4026-B4F0-06BD326598A6Q26866480-D8DE32BD-C328-4901-9AAA-C2435D9A5C0DQ28080521-194D5BC7-2172-4F6A-B779-78EAB11C5420Q28087304-34442D7E-F35C-47D8-B0B8-F3682B56A5E7Q28580246-D9B0EA0B-DD0C-4312-8273-8248B6F4CEBCQ28817901-824A91C6-4574-40E3-8189-25CE4EB89BBFQ30423561-DF9A7A3E-518B-4A83-909A-33CB841010C6Q30438880-B8C4E6E2-CD6F-44AA-9937-7825A545637EQ31154570-FE609ACA-A7F9-4557-8D62-DBB2EBA2D563Q33413024-0FCF1305-50CB-47A0-AA9B-0FCDC679F196Q33537990-ED242EA7-1BA6-462B-860D-DAAE5A259FDCQ33656631-8D2023E7-E265-46A7-BC06-E592CFCECD8BQ33761954-DED1644C-A5D7-4F04-B90C-5A8749F87786Q33803402-57B77C59-75D1-4EDC-B72A-9CC3C905A9CDQ33816616-8E2765A6-66AE-404A-A300-D8FEC025E977Q33886401-6E78D113-885D-4737-8110-E9FD4E8A1323Q34050210-6D45AE5E-44D0-4E6B-B8D4-92AC1C4D5ECDQ34237738-0482994C-E721-4918-BF06-AB4CC3C35A08Q34254557-B3394D15-7B07-4819-8778-8B30BEF5C781Q34472190-C8FCA19F-790C-454F-8CE6-993B342D48EEQ34527184-251EA7A9-0539-453C-9AE3-050852DC0772Q34554570-C571DF23-E330-48BC-B47F-27E283980574Q34731332-4CEFC818-D904-4D4F-AA78-1FB7B75EB222Q34836376-C1880C08-9A3D-4EF2-801F-F7D89BA48B83Q35022648-DB9A66AD-D1AF-4589-B41E-C8F6CBB8EC1DQ35079607-80C948EB-DEC6-40DC-AEF4-C742794E75CEQ35084876-B5C779DF-0674-42E7-B0F1-95A6B903C31CQ35133177-67AF0E35-DD48-4CE9-906E-77606D0C97EBQ35143026-6439373E-047D-40FA-8CC4-EB5FDF6053DCQ35224255-852B1D93-8BCC-48AC-9265-68F9972D9361Q35673446-FDA140B6-479D-4FEE-A93A-17B79B270C93Q35730481-1BE5367E-678D-4791-9ECA-ACF0B8CB672DQ35884405-4E0C43D9-A9EF-4F55-ABA3-0FC917865349Q35924532-B7615B8A-6591-47A8-AE8C-A8E5BEC1D470Q36153911-3C566858-FB85-4F6C-8A42-EA9099FD4085Q36200281-87D0D006-4DED-4842-A992-87C9A2D33168Q36222092-27CF3637-F2A5-4B88-A749-59CF9AD0AC35
P2860
Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Macrophages in mouse type 2 di ...... and progressive renal injury.
@en
Macrophages in mouse type 2 di ...... and progressive renal injury.
@nl
type
label
Macrophages in mouse type 2 di ...... and progressive renal injury.
@en
Macrophages in mouse type 2 di ...... and progressive renal injury.
@nl
prefLabel
Macrophages in mouse type 2 di ...... and progressive renal injury.
@en
Macrophages in mouse type 2 di ...... and progressive renal injury.
@nl
P2093
P1433
P1476
Macrophages in mouse type 2 di ...... and progressive renal injury.
@en
P2093
Elyce Ozols
Fiona Chow
Gregory H Tesch
Robert C Atkins
P304
P356
10.1111/J.1523-1755.2004.00367.X
P407
P577
2004-01-01T00:00:00Z
P5875
P6179
1034517277